Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone in Adult ADHD
NCT01721330Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2012
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Naltrexone with Placebo (2 arms). Primary endpoint: Adult Investigator Symptom Rating Scale at 6 weeks. Started Nov 2012; status: terminated.
02
Drugs
naltrexone
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01721330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01721330.